ATXI · Avenue Therapeutics, Inc. · Investor Relations
$0.38
-0.05 (-10.71%)
At close · Mar 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Volume · Mar 19
173.84K
Avg daily vol (3M)
426.7K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-30 | Annual Meeting of Stockholders | Shareholder meeting |
| 2024-10-15 | Maxim Group’s 2024 Healthcare Virtual Summit | Event |
| 2024-06-24 | Annual Meeting of Stockholders | Shareholder meeting |
| 2024-04-04 | Avenue Therapeutics KOL Event | Event |
| 2024-01-18 | Sidoti January Micro-Cap Investor Conference | Conference |
| 2023-09-13 | H.C. Wainwright 25th Annual Global Investment Conference | Conference |
| 2023-06-22 | Annual Meeting of Stockholders | Shareholder meeting |
| 2023-05-04 | Aegis Capital Virtual Conference Avenue Therapeutics Presentation | Conference |
| 2022-12-28 | Annual Meeting of Stockholders | Shareholder meeting |
Source: https://ir.avenuetx.com/